Course Description
ADHD in older adults is an underrecognized and undertaught topic, creating a significant knowledge gap among psychiatric providers and pharmacists. Diagnostic criteria developed for children and adolescents often fail to capture the unique symptom patterns and cognitive changes seen in older adults, such as differences in working memory, inhibition, and processing speed. Treatment in this population can be challenging and controversial, particularly with stimulant use, due to increased risks like cardiovascular events and medication intolerance. While pharmacologic options may be considered, evidence supporting their safety and efficacy in older adults remains limited, and guidelines rarely address this age group. This webinar will explore the clinical presentation of ADHD in older adults, review current research and treatment considerations, and provide practical strategies for managing ADHD in this population with caution and confidence.
Learning Objectives
- Describe diagnostic and clinical features of ADHD in older adults.
- Assess the safety of commonly used ADHD treatments in older adults.
- Outline a treatment plan for ADHD in older adults based on available evidence.
Target Audience
If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.
Faculty
View biographical information
Clayton English, PharmD, MS, BCPP, BCGP, FAAPP
Assistant Professor | University of Washington School of Pharmacy
Dr. Clayton English is an Assistant Professor of Pharmacy at the University of Washington School of Pharmacy, where he practices in the ambulatory care setting as a psychiatric pharmacist at Harborview Mental Health and Addiction Services in Seattle, Washington, and supports the UW Medicine PGY-2 Psychiatry Residency Program. He serves as the assistant director of research in the Center for Pharmacy Practice Transformation which is embedded in the school of pharmacy. The central focus of his research program and position at the UW is to strengthen the sustainable and scalable delivery of pharmacist-provided mental health services by equipping both specialists and generalist pharmacists with the skills and support needed to deliver accessible, safe, and equitable care. He is board-certified in Psychiatric Pharmacy and Geriatric Pharmacy and is an inaugural fellow of the American Association of Psychiatric Pharmacists. From 2010 to 2022, he was a faculty member at Albany College of Pharmacy and Health Sciences and practiced as a clinical pharmacy specialist in psychiatry at the University of Vermont Medical Center.
Dr. English’s clinical and research interests focus on psychiatric pharmacy, including mental health services provided by pharmacists, treatment of serious mental illness, and the safety of medications used for psychosis, mood disorders, and adult ADHD. Passionate about interprofessional education and the well-being of students and residents, he actively contributes to professional development through his work with the American Association of Psychiatric Pharmacists (AAPP), including serving as a Senior Editor for the AAPP Psychiatric Pharmacotherapy Review Book and Course and currently serves as the president of the AAPP Foundation. He has been recognized for excellence in teaching and contributions to pharmacy practice, receiving the Award of Excellence in Academic Teaching from the University of Vermont Psychiatry Residency Program in 2012, 2017, and 2019, and being named Vermont Pharmacist of the Year by the Vermont Society of Health-System Pharmacists in 2013.
Dr. English completed both his undergraduate and Doctor of Pharmacy degrees at the University of Connecticut. He holds a masters of science degree in health services research from the University of Washington School of Public Health and he completed his post-doctoral residency training in psychiatric pharmacy at Nova Southeastern University.
Course Requirements
To receive ACPE credit for this session, you must:
- Register for this course.
- Review the full content of the activity and reflect upon its teachings.
- Complete the evaluation at the end of the activity.
- Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Continuing Education Credit and Disclosures
Activity Dates: 10/1/2026-10/1/2029
ACPE Contact Hours: 1.25
ACPE Number: 0284-0000-##-###-###-P (Application)
 | The American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. |
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.
View Faculty and Program Planning Committee Disclosures of Interest
Faculty: Clayton English, PharmD, MS, BCPP, BCGP, FAAPP has nothing to disclose
Planning Committee: Members and disclosures listed here.
View AAPP's Disclaimer and Disclosure Declarations
AAPP Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Unlabeled Use Disclosure: Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. CME Outfitters, LLC, the faculty, planners, and American Association of Psychiatric Pharmacists do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
View AAPP's Privacy Policy
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
View AAPP's Fair Balance and Integrity Statement
It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.